Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Care | 11 | 2023 | 693 | 3.530 |
Why?
|
| Ultrasonography | 19 | 2025 | 1004 | 3.440 |
Why?
|
| Point-of-Care Systems | 9 | 2025 | 193 | 3.180 |
Why?
|
| Laryngoscopy | 3 | 2022 | 157 | 1.390 |
Why?
|
| Echocardiography | 7 | 2023 | 1125 | 1.330 |
Why?
|
| Intensive Care Units, Pediatric | 4 | 2018 | 485 | 1.270 |
Why?
|
| Intracranial Hypertension | 2 | 2021 | 133 | 1.240 |
Why?
|
| Critical Illness | 5 | 2023 | 626 | 1.130 |
Why?
|
| Catheterization, Central Venous | 2 | 2020 | 135 | 1.060 |
Why?
|
| Heart Arrest | 2 | 2023 | 376 | 0.980 |
Why?
|
| Vocal Cords | 2 | 2021 | 67 | 0.890 |
Why?
|
| Ultrasonography, Interventional | 4 | 2021 | 205 | 0.820 |
Why?
|
| Optic Nerve | 2 | 2021 | 119 | 0.780 |
Why?
|
| Pneumothorax | 1 | 2020 | 82 | 0.640 |
Why?
|
| Sepsis | 2 | 2021 | 518 | 0.600 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 186 | 0.600 |
Why?
|
| Child | 20 | 2025 | 25763 | 0.550 |
Why?
|
| Heart Diseases | 2 | 2019 | 521 | 0.530 |
Why?
|
| Anesthesiology | 1 | 2018 | 103 | 0.510 |
Why?
|
| Hospitals, Pediatric | 2 | 2025 | 789 | 0.500 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 18 | 0.490 |
Why?
|
| Venae Cavae | 1 | 2015 | 11 | 0.490 |
Why?
|
| Trachea | 1 | 2016 | 212 | 0.460 |
Why?
|
| Humans | 31 | 2025 | 133552 | 0.420 |
Why?
|
| Pediatrics | 3 | 2025 | 1217 | 0.420 |
Why?
|
| Pandemics | 1 | 2021 | 1190 | 0.410 |
Why?
|
| Intubation, Intratracheal | 1 | 2016 | 291 | 0.410 |
Why?
|
| Heart Atria | 1 | 2015 | 337 | 0.400 |
Why?
|
| Program Evaluation | 1 | 2015 | 455 | 0.400 |
Why?
|
| Sensitivity and Specificity | 3 | 2022 | 2163 | 0.380 |
Why?
|
| Point-of-Care Testing | 2 | 2023 | 32 | 0.380 |
Why?
|
| Oxazolidinones | 1 | 2011 | 34 | 0.360 |
Why?
|
| Acidosis, Lactic | 1 | 2011 | 30 | 0.360 |
Why?
|
| Acetamides | 1 | 2011 | 51 | 0.360 |
Why?
|
| Lactic Acid | 1 | 2011 | 166 | 0.350 |
Why?
|
| Catheterization, Peripheral | 2 | 2021 | 129 | 0.270 |
Why?
|
| Infant, Newborn | 7 | 2024 | 8592 | 0.240 |
Why?
|
| Hospital Medicine | 1 | 2025 | 33 | 0.230 |
Why?
|
| Nicardipine | 1 | 2024 | 17 | 0.220 |
Why?
|
| Nitroprusside | 1 | 2024 | 42 | 0.220 |
Why?
|
| Fatal Outcome | 2 | 2017 | 376 | 0.210 |
Why?
|
| Competency-Based Education | 1 | 2023 | 76 | 0.200 |
Why?
|
| Infant | 8 | 2024 | 13174 | 0.190 |
Why?
|
| ROC Curve | 1 | 2022 | 609 | 0.170 |
Why?
|
| Larynx | 1 | 2021 | 78 | 0.170 |
Why?
|
| Ribs | 1 | 2020 | 54 | 0.170 |
Why?
|
| Computed Tomography Angiography | 1 | 2021 | 211 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 2511 | 0.160 |
Why?
|
| Intracranial Pressure | 1 | 2020 | 212 | 0.150 |
Why?
|
| Positive-Pressure Respiration | 1 | 2019 | 85 | 0.150 |
Why?
|
| Heart | 1 | 2023 | 749 | 0.150 |
Why?
|
| Anesthesia, General | 1 | 2019 | 126 | 0.150 |
Why?
|
| Certification | 1 | 2018 | 71 | 0.140 |
Why?
|
| Child, Preschool | 5 | 2019 | 14806 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 1152 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2017 | 468 | 0.110 |
Why?
|
| Adult | 4 | 2023 | 31833 | 0.100 |
Why?
|
| Adolescent | 5 | 2021 | 20518 | 0.100 |
Why?
|
| Intensive Care Units | 1 | 2016 | 537 | 0.100 |
Why?
|
| Linezolid | 1 | 2011 | 27 | 0.090 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 559 | 0.090 |
Why?
|
| Lung | 1 | 2019 | 1558 | 0.090 |
Why?
|
| Female | 6 | 2021 | 71541 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 516 | 0.090 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2017 | 641 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 3085 | 0.070 |
Why?
|
| Male | 5 | 2017 | 65790 | 0.070 |
Why?
|
| Mitochondria | 1 | 2011 | 744 | 0.060 |
Why?
|
| Vasodilator Agents | 1 | 2024 | 214 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2021 | 103 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2024 | 410 | 0.040 |
Why?
|
| Catheters | 1 | 2021 | 84 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2024 | 1420 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 6575 | 0.040 |
Why?
|
| Boston | 1 | 2016 | 123 | 0.030 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2016 | 18 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 1211 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 3739 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2016 | 250 | 0.030 |
Why?
|
| Cardiac Tamponade | 1 | 2016 | 38 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 3030 | 0.030 |
Why?
|
| Pericardial Effusion | 1 | 2016 | 71 | 0.030 |
Why?
|
| Thoracic Injuries | 1 | 2016 | 93 | 0.030 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2016 | 79 | 0.030 |
Why?
|
| Observer Variation | 1 | 2016 | 312 | 0.030 |
Why?
|
| Fluid Therapy | 1 | 2016 | 149 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 3977 | 0.030 |
Why?
|
| Shock, Septic | 1 | 2016 | 156 | 0.030 |
Why?
|
| Heart Valve Diseases | 1 | 2016 | 181 | 0.030 |
Why?
|
| Aortic Diseases | 1 | 2016 | 203 | 0.030 |
Why?
|
| Acute Coronary Syndrome | 1 | 2016 | 238 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2016 | 381 | 0.030 |
Why?
|
| Young Adult | 2 | 2016 | 9869 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2021 | 17403 | 0.020 |
Why?
|
| United States | 1 | 2025 | 11682 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2016 | 1063 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 6577 | 0.020 |
Why?
|